Matthew T Drake MD

PubMed

• Bone Health in Patients With Adrenal Adenomas and Hypercortisolism: A Multicenter Cross-Sectional Study.
  Prerna Dogra, Lana Šambula, Jasmine Saini, Matthew T Drake, Shobana Athimulam
  Clinical Endocrinology. 2025-10-07
• Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?
  Hanna Taipaleenmäki, Matthew T Drake
  JBMR Plus. 2025-09-01
• 2 citations
  Senescence profiling of monoclonal gammopathies reveals paracrine senescence as a crucial defense against disease progression.
  Gabriel Alvares Borges, Marta Diaz-delCastillo, Angelo J Guilatco, Bilal Mohamad El-Masri, Fatima A Mustapha
  Leukemia. 2025-05-01

Journal Articles

• Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women  
  Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S, Obstet Gynecol Surv, 5/1/2011
• Corrigendum to "Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women"  
  Undale A, Srinivasan B, Drake M, McCready L, Atkinson E, Peterson J, Riggs BL, Amin S, Modder UI, Khosla S, Bone, 1/1/2011
• Vitamin D deficiency in multiple myeloma  
  Drake MT, Ng AC, European journal of Clinical and Medical Oncology, 1/1/2010
• ADP-ribosylation factor 1 dependent clathrin-coat assembly on synthetic liposomes  
  Zhu Y, Drake MT, Kornfeld S, Proc Natl Acad Sci U S A, 4/27/1999
• Join now to see all

Books/Book Chapters

• Multiple myeloma: diagnosed and treatment. 
  Chapter: Myeloma bone disease. 
  Page 211 - 223Drake MTEditors: Gertz MA; Rajkumar SV.Springer, New York, NY2014
• Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 
  Chapter: The Role of Sex Steroids in the Pathogenesis of Osteoporosis. 
  Page 367 - 375Drake MT, Khosla SEdition 8tj,2013
• Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 
  Chapter: Role of sex steroids in the pathogenesis of osteoporosis. 
  Page 208 - 213Drake MT, Khosla SEdition 7th,2009

Abstracts/Posters

• Controversies in Pharmaceutical Management of Osteoporosis Therapy
  Drake MT, American Association of Clinical Endocrinologists Annual Meeting, 5/1/2014
• Monoclonal Gammopathy Associated Bone Loss
  Drake MT, Dresden University Medical Center, Dresden, Germany, 4/1/2014
• Bone loss in monoclonal gammopathy of undetermined significance.
  Drake MT, Advances in Mineral Metabolism Annual Meeting, 4/1/2014
• Skeletal Structural Changes and Fracture Risk in Monoclonal Gammopathy of Undetermined Significance.
  Drake MT, Central Society for Clinical and Translational Research Annual Meeting, Chicago, IL, 4/1/2014
• Bone Mineral Metabolism in Chronic Kidney Disease
  Drake MT, Nephrology Update - West Lake Forum, Hangzhou, China, 3/1/2014
• The Clinical Spectrum of Hypophosphatasia.
  Drake MT, Soft Bones Patient Education Meeting, San Diego, CA, 2/1/2014
• Circulating Sclerostin as a Marker of Bone Health and Disease
  Drake MT, Plenary Symposium American Society for Bone and Mineral Research Annual Meeting, 10/1/2013
• Osteoporosis in Men
  Drake MT, Endocrine Society Annual Meeting, San Francisco, CA, 6/1/2013
• Suppression of osteoblastogenesis in human MSCs co-cultured with human multiple myeloma cells.
  Zhang W, Peterson J, Kassem M, Drake M, ASBMR Annual Meeting, 1/1/2013
• Estrogen reduces bone sost mRNA and circulating sclerostin levels in postmenopausal women.
  Roforth M, Fujita K, Demaray S, McGregor U, Kirmani S, McCready L, Peterson J, Drake M, David Monroe D, Khosla S, ASBMR Annual Meeting, 1/1/2013
• Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture.
  Fujita K, Roforth M, Peterson J, Kirmani S, Drake M, McCready L, Monroe D, Khosla S, ASBMR Annual Meeting, 1/1/2013
• Altered cortical microarchitecture and bone metabolism in patients with monoclonal gammopathy of undetermined significance.
  Farr J Zhang W, Jacques R, Ng A, McCready L, Drake M, ASBMR Annual Meeting, 1/1/2013
• Altered cortical microarchitecture and bone metabolism in patients with monoclonal gammopathy of undetermined significance.
  Drake MT, Zhang W, Kumar SK, Jacques R, Ng A, McCready LK, Rajkumar SV, Farr JN, 13th International Conference on Cancer Induced Bone Disease, 1/1/2013
• Phase I trial of rituximab, cladribine and temsirolimus (rct) for initial therapy of mantle cell lymphoma.
  Inwards DJ, Fishkin P, LaPlant BR, Drake MT, Kurtin P, Nikcevich D, Wender D, Lair B, Witzig TE, Blood, 11/1/2012
• Measurement of Sclerostin and DKK-1 in Serum: What Insights Has This Provided?
  Drake MT, European Calcified Tissue Society, Stockholm, Sweden, 5/1/2012
• Measurement of sclerostin and DKK-1 in serum: what insights has this provided?
  Drake M, Bone, 5/1/2012
• Skeletal Health in Cancer Patients
  Drake MT, Mayo Clinic Endocrine Course, Mallorca, Spain, 4/1/2012
• Bone Turnover Markers.
  Drake MT, Mayo Clinic Endocrine Course, Mallorca, Spain, 4/1/2012
• Zhang W, Dingli D, Russell S, Drake M, ASBMR Annual Meeting, 1/1/2012
• Hypophosphatasia Diagnosed in Adults: Differential Features Based on Sex, Presence of Fractures, and Symptoms at Presentation.
  Berkseth K, Tebben P, Drake M, Wermers R, J Bone Miner Res, 1/1/2012
• Skeletal Health Across the Monoclonal Gammopathy Spectrum.
  Drake MT, Washington University School of Medicine, St. Louis, MO, 12/1/2011
• Understanding Bone Disease Across the Monoclonal Gammopathy Spectrum.
  Drake MT, University of Arkansas Medical Sciences Winthrop P. Rockefeller Cancer Institute Grand Rounds, 2/1/2011
• Vitamin D levels in patients undergoing PBSCT.
  Zeldenrust S, Drake M, Gertz M, 13th International Myeloma Workshop, 1/1/2011
• Relationship of adiposity to volumetric BMD and microstructural parameters in men and women across the adult lifespan.
  Ng AC, Melton LJ, Atkinson EJ, Achenbach SJ, Drake MT, Khosla S, Amin S, Osteoporos Int, 12/1/2010
• Current Issues in Osteoporosis: Long-term Complications of Bisphosphonates and Use of Denosumab.
  Drake MT, Annual Midwest Regional American Association of Clinical Endocrinologists Meeting, 11/1/2010
• Join now to see all

Lectures

• Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Optimizing Bone Health in Multiple Myeloma. 
  Atlanta, GA - 5/1/2014
• Monoclonal gammopathy-associated bone loss. 
  10/1/2013
• Management of Bone Disease in Multiple Myeloma. 
  Dallas, TX - 6/1/2011
• Suppression of FSH in postmenopausal women has no effect on bone resorption markers. 
  3/1/2011
• Join now to see all